Stents for LBO
Appearance
Selecting a stentable lesion
[edit | edit source]- Best between splenic flexure and rectosigmoid
- Rectum beyond rectosigmoid junction generally causes unbearable tenesmus, and carries a high risk of stent migration
- Areas of acute angulation (flexures) are hard in general
- Proximal colon is hard, but theoretically feasible by specialists
Indications (generally only malignant indications at this stage)
[edit | edit source]- Palliation for patients not fit for resection, or with widespread metastases
- Pre-operative decompression
- Clinical stabilisation
- Allow bowel prep
- Pre-op colonoscopy to exclude synchronous lesions
- Allows one-stage resection and anastomosis
- Operate 5-10 days later
Equipment
[edit | edit source]- Covered vs uncovered
- Covered are less likely to get tumour ingrowth (3.8% vs 14.5%)
- Uncovered are less likely to migrate (1.8% vs 21.1%)
- Uncovered are generally preferred
- Generally deployed through the scope
Preparation
[edit | edit source]- In partial obstruction, prep gently with PEG
- In complete obstruction, consider giving an enema
- Prophylactic Abx
- If in doubt about ability to traverse and stent, give a contrast enema - if contrast won't pass, neither will the guidewire
Technique
[edit | edit source]- Try to pass the lesion
- Don't dilate the lesion
- Pass a guidewire
- Confirm placement with fluoroscopy
- Pass stent over the top and expand in 1-2cm increments with fluoroscopy guidance
Post-procedure
[edit | edit source]- Low-residue diet
- Avoid vegetables, fruits and whole grains
- Stool softeners
Efficacy
[edit | edit source]- Technical success - 97%
- Able to decompress colon through stent within 96 hours - 97%
- For palliation, rate of reintervention is 20%
Complications
[edit | edit source]- Perforation (<5%)
- Immediate or delayed (erosion)
- High-risk with bevacizumab or radiation
- Migration 11%
- High risk
- Benign lesions (doesn't embed)
- Stent too small
- Tumour shrinks after therapy
- High risk
- Rectal bleeding - significant bleeding is rare
- Recurrent obstruction
- Tumour can grow in at ends of stent or through the stent - can be treated by argon photocoagulation or laser or another stent